How to Switch From OatMeds to PlexusDx Without Missing a Dose

Last reviewed: September 11, 2026 Last updated: September 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Switching from OatMeds to PlexusDx is straightforward if you time your PlexusDx intake to overlap with your final OatMeds shipment. The core decision is billing flexibility: OatMeds starter bundles cost $99–$133 per month when prepaid quarterly ($297–$399 upfront), while PlexusDx runs $189 (semaglutide) or $289 (tirzepatide) month-to-month with no upfront commitment. OatMeds holds a price advantage on a 12-month prepaid basis—$1,188/year for semaglutide starter bundles vs PlexusDx's $2,268/year—but requires $297–$499 every 12 weeks. PlexusDx month-to-month plans carry no prepayment and allow you to pause or cancel without forfeiting bundled doses. For most people, the transfer window is 7–10 days before your next OatMeds shipment is due.

At-a-glance: OatMeds vs PlexusDx

OatMeds pricing captured September 4, 2026 from oatmeds.com/products/glp1-treatments. PlexusDx pricing captured July 17–23, 2026. Monthly-rate figures for OatMeds prepaid bundles are our calculation based on published 12-week bundle totals.

Normalized pricing: month-to-month vs prepaid bundles

OatMeds structures its pricing around 12-week prepaid bundles and separate monthly plans. PlexusDx operates exclusively month-to-month. To compare like-for-like, we calculate the 12-month total for each path.

Semaglutide injection: 12-month comparison

• OatMeds starter bundle (prepaid quarterly): $297 upfront every 12 weeks = 4 × $297 = $1,188 total ($99/month prepaid rate, our calculation). Requires $297 upfront payment four times over the year.
• OatMeds monthly plan (ongoing): $199/month × 12 = $2,388 total. No prepayment required; billed monthly.
• PlexusDx month-to-month: $189/month × 12 = $2,268 total (our calculation). No prepayment; billed monthly.

Verdict: OatMeds starter bundle saves $1,080 over 12 months vs PlexusDx if you can commit $297 upfront every quarter. PlexusDx saves $120/year vs OatMeds' monthly plan and carries no quarterly prepayment.

Tirzepatide injection: 12-month comparison

• OatMeds starter bundle (prepaid quarterly): $399 upfront every 12 weeks = 4 × $399 = $1,596 total ($133/month prepaid rate, our calculation). Requires $399 upfront payment four times over the year.
• OatMeds monthly plan (ongoing): $229/month × 12 = $2,748 total. No prepayment; billed monthly.
• PlexusDx month-to-month: $289/month × 12 = $3,468 total (our calculation). No prepayment; billed monthly.

Verdict: OatMeds holds a clear price advantage for tirzepatide. The starter bundle saves $1,872/year vs PlexusDx; even OatMeds' monthly plan saves $720/year. The trade-off is flexibility: PlexusDx lets you pause or cancel monthly without forfeiting a prepaid bundle.

Step-by-step: switching without a gap

The core challenge is timing your PlexusDx intake so your first shipment arrives before your current OatMeds supply runs out. Here's the standard sequence:

1. Check your OatMeds shipment schedule. If you're on a 12-week bundle, count the weeks remaining. If you're on monthly billing, note your next auto-ship date. Most people have a 4-week supply on hand.
2. Start your PlexusDx intake 7–10 days before your next OatMeds dose is due. PlexusDx typically ships within 3–5 business days of provider approval. Building in a 7–10 day buffer accounts for intake review, approval, pharmacy fulfillment, and transit.
3. Complete the PlexusDx online intake. The intake collects medical history, current medications, weight-loss goals, and contraindication screening. A licensed clinician reviews your submission and determines whether a prescription is appropriate.
4. Receive provider approval and prescription. If approved, PlexusDx sends your prescription to a licensed 503A compounding pharmacy. You'll receive tracking within 1–2 business days of approval.
5. Receive your first PlexusDx shipment. Medication arrives with dosing instructions, injection supplies (if applicable), and support contact information. Your first dose timing depends on where you are in your current OatMeds cycle.
6. Cancel or pause your OatMeds subscription. Contact OatMeds support to stop future shipments. If you're mid-bundle, confirm whether any refund or credit applies (policies vary by provider and should be confirmed directly with OatMeds).

Dose continuity: If you're switching at the same compound and dose level (for example, 1 mg semaglutide weekly at OatMeds to 1 mg semaglutide weekly at PlexusDx), most clinicians recommend continuing on your established schedule without a washout period. If your PlexusDx provider prescribes a different starting dose or suggests a titration adjustment, follow the new dosing calendar provided with your shipment. Never adjust dose timing or strength without explicit provider instruction.

Prescription transfer: PlexusDx issues a new prescription through its own provider network; it does not "transfer" your existing OatMeds prescription. Your PlexusDx intake functions as a new clinical evaluation. If your current dose is working well, note that in your intake—it helps the reviewing clinician understand your treatment history—but the final prescription decision rests with the PlexusDx provider.

Decision factors: when the switch makes sense

OatMeds holds a price advantage if you can prepay quarterly

OatMeds' starter bundles deliver the lowest per-month cost in this comparison: $99/month rate for semaglutide, $133/month for tirzepatide, when paid $297–$399 upfront every 12 weeks. Over 12 months, that's $1,188 (sema) or $1,596 (tirz) vs PlexusDx's $2,268 (sema) or $3,468 (tirz). The savings are substantial if:

• You have $297–$399 available every quarter without straining your budget.
• You're confident you'll continue treatment for the full 12-week cycle (pausing mid-bundle may forfeit prepaid doses—confirm OatMeds' specific refund policy).
• Price is your primary decision variable and you're comfortable with the prepayment model.

Even OatMeds' monthly plans ($199 sema, $229 tirz) cost less than PlexusDx month-to-month for tirzepatide, though PlexusDx edges ahead by $10/month ($120/year) for semaglutide on a monthly basis.

PlexusDx offers month-to-month flexibility with no bundled commitment

PlexusDx month-to-month billing means:

• No upfront lump sum; your first charge is $189 (sema) or $289 (tirz).
• You can pause or cancel after any monthly cycle without forfeiting prepaid doses.
• Budgeting is predictable: the same flat rate every month, regardless of dose level.
• No quarterly re-commitment decision; you stay enrolled until you choose to stop.

This model suits people who:

• Prefer monthly cash flow over quarterly prepayment.
• Want the option to pause treatment (for example, during travel, pregnancy planning, or financial variability) without losing prepaid medication.
• Value billing simplicity and transparent ongoing costs.

Both programs use compounded medications from 503A pharmacies

OatMeds and PlexusDx both dispense compounded semaglutide and tirzepatide. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. Neither provider's compounded product is the same as branded Wegovy, Ozempic, Saxenda, Zepbound, or Mounjaro. PlexusDx works with licensed 503A compounding pharmacies.

Choose OatMeds if…

• You can comfortably prepay $297–$399 every 12 weeks and want the lowest per-month cost available in this comparison.
• You're confident in sustained treatment adherence over multi-month cycles.
• Price optimization is your top priority and you're willing to commit to a bundled purchase model.
• You prefer OatMeds' optional B12 or glycine add-ons (note: the introductory $179/month rate for B12/glycine plans is lower than the standalone medication monthly rate; confirm the ongoing refill price and total cost at checkout).

Choose PlexusDx if…

• You want month-to-month billing with no upfront commitment or bundled prepayment.
• You value the flexibility to pause or cancel after any monthly cycle without forfeiting prepaid doses.
• You prefer predictable, flat-rate monthly charges that never change with dose adjustments.
• You're switching from a prepaid model and want to avoid renewing a multi-month bundle while evaluating a new provider.
• For semaglutide specifically, you want to save $10/month ($120/year) vs a competitor's monthly plan while keeping month-to-month flexibility.

What you won't get at PlexusDx (and why it might matter)

PlexusDx does not offer:

• Prepaid bundle discounts. You pay the same $189 or $289 rate every month. There is no quarterly or annual prepay option that lowers the per-month cost.
• B12 or glycine add-ons. PlexusDx dispenses GLP-1 compounds only; supplemental vitamins or amino acids are not part of the medication offering.
• Branded oral GLP-1 or Zepbound access. OatMeds provides pathways to branded Wegovy/Foundayo pills and Zepbound. PlexusDx focuses exclusively on compounded semaglutide and tirzepatide (injection and oral capsule forms).

If any of these features is central to your treatment plan, confirm availability and pricing with OatMeds directly before switching.

Methodology and freshness

OatMeds pricing (all plans, both compounds) was captured September 4, 2026 from the public-facing product page at oatmeds.com/products/glp1-treatments. PlexusDx pricing was captured July 17–23, 2026 from live product pages. Monthly-rate figures for OatMeds prepaid bundles are our calculation, derived by dividing the published 12-week bundle price by three. Twelve-month totals are our calculation, using the method shown (4 × quarterly bundle price for OatMeds prepaid paths; 12 × monthly rate for all month-to-month paths). OatMeds' displayed introductory $179/month rate for B12 and glycine add-on plans is lower than the standalone medication monthly rate; we note this inconsistency and recommend confirming the ongoing refill price and total cost at checkout. No review volume or rating data was available for OatMeds at the time of research. PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com). All prices and policies are subject to change; confirm current rates and terms at checkout before committing.

Frequently Asked Questions

Can I transfer my OatMeds prescription directly to PlexusDx?

No. PlexusDx issues a new prescription through its own licensed provider network after you complete an online intake. The intake functions as a new clinical evaluation; your PlexusDx provider will review your medical history, current medications, and weight-loss goals to determine whether a prescription is appropriate. You cannot transfer an active OatMeds prescription to PlexusDx.

Will I have a gap in medication if I switch mid-cycle?

Most people avoid a gap by starting the PlexusDx intake 7–10 days before their next OatMeds dose is due. PlexusDx typically ships within 3–5 business days of provider approval. If your timing is tight, contact PlexusDx support after intake submission to request expedited review, though approval speed depends on clinician availability and cannot be guaranteed.

Does PlexusDx offer a prepaid bundle or annual discount like OatMeds?

No. PlexusDx operates exclusively on month-to-month billing at a flat rate: $189/month for semaglutide injection, $289/month for tirzepatide injection. There is no multi-month prepaid option or bulk discount. The trade-off is flexibility—you can pause or cancel after any monthly cycle without forfeiting prepaid doses.

What happens to my unused OatMeds doses if I cancel mid-bundle?

That depends on OatMeds' refund and cancellation policy, which may vary by plan type and how far into the 12-week cycle you are. Contact OatMeds support directly to confirm whether any refund, credit, or prorated adjustment applies. PlexusDx cannot advise on another provider's internal policies.

Can I pause my PlexusDx subscription if I need a treatment break?

Yes. PlexusDx month-to-month billing allows you to pause or cancel after any monthly cycle. Contact support before your next billing date to request a pause. There is no penalty for pausing and no prepaid balance to forfeit. When you're ready to resume, you'll complete a brief re-evaluation intake to confirm ongoing eligibility.

Sources

• PlexusDx product pages and pricing (plexusdx.com/products/semaglutide-injection, plexusdx.com/products/tirzepatide-injection), accessed July 17–23, 2026.
• OatMeds GLP-1 treatments product page (oatmeds.com/products/glp1-treatments), accessed September 4, 2026.
• PlexusDx Trustpilot profile (trustpilot.com/review/plexusdx.com), accessed September 9, 2026.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.